期刊文献+

Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population 被引量:4

Genetic variants in TP53 and MDM2 associated with male infertility in Chinese population
在线阅读 下载PDF
导出
摘要 The TP53, a transcriptional regulator and tumor suppressor, is functionally important in spermatogenesis. MDM2 is a key regulator of the p53 pathway and modulates p53 activity. Both proteins have been functionally linked to germ cell apoptosis, which may affect human infertility, but very little is known on how common polymorphisms in these genes may influence germ cell apoptosis and the risk of male infertility. Thus, this study was designed to test whether three previously described polymorphisms 72Arg〉Pro (rs1042522) and the Ex2+ 19C〉T (rs2287498) in TP53, and the 5' untranslated region (5' UTR) 309T〉G (rs937283) in MDM2, are associated with idiopathic male infertility in a Chinese population. The three polymorphisms were genotyped using OpenArray assay in a hospital-based case-control study, including 580 infertile patients and 580 fertile controls. Our analyses revealed that TP53 Ex2-1-19C〉T and MDM2 309T〉G polymorphisms are associated with male infertility. Furthermore, we detected a nearly statistically significant additive interaction between TP53 rs2287498 and MDM2 rs937283 for the development of male infertility (Pinteraction--O-055)- In summary, this study found preliminary evidence, demonstrating that genetic variants in genes of the TP53 pathway are risk factors for male infertility. The TP53, a transcriptional regulator and tumor suppressor, is functionally important in spermatogenesis. MDM2 is a key regulator of the p53 pathway and modulates p53 activity. Both proteins have been functionally linked to germ cell apoptosis, which may affect human infertility, but very little is known on how common polymorphisms in these genes may influence germ cell apoptosis and the risk of male infertility. Thus, this study was designed to test whether three previously described polymorphisms 72Arg〉Pro (rs1042522) and the Ex2+ 19C〉T (rs2287498) in TP53, and the 5' untranslated region (5' UTR) 309T〉G (rs937283) in MDM2, are associated with idiopathic male infertility in a Chinese population. The three polymorphisms were genotyped using OpenArray assay in a hospital-based case-control study, including 580 infertile patients and 580 fertile controls. Our analyses revealed that TP53 Ex2-1-19C〉T and MDM2 309T〉G polymorphisms are associated with male infertility. Furthermore, we detected a nearly statistically significant additive interaction between TP53 rs2287498 and MDM2 rs937283 for the development of male infertility (Pinteraction--O-055)- In summary, this study found preliminary evidence, demonstrating that genetic variants in genes of the TP53 pathway are risk factors for male infertility.
出处 《Asian Journal of Andrology》 SCIE CAS CSCD 2012年第5期691-694,共4页 亚洲男性学杂志(英文版)
关键词 APOPTOSIS male infertility MDM2 POLYMORPHISMS TP53 apoptosis male infertility MDM2 polymorphisms TP53
  • 相关文献

参考文献2

二级参考文献19

  • 1Vogt PH, Edelman A, Kirsch S, Henegariul O, Hirschmann Pet al. Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet 1999; 5: 933-45.
  • 2Vogt PH. Azoospermia factor (AZF) in Yql 1: towards a molecular understanding of its function for human male fertility and spermatogenesis. Reprod Biomed Online 2005; 10: 81-93.
  • 3Hopps CV, Mielnik A, Goldstein M, Palermo GD, Rosenwaks Z etal. Detection of sperm in men with Y chromosome microdeletions of the AZFa, AZFb and AZFc regions. Hum Reprod 2003; 18; 1660-65.
  • 4Kamp C, Huellen K, Fernandes S, Sousa M, Schlegel PN etal. High deletion frequency of the complete AZFa sequence in men with Sertoli-cell-only syndrome. Mol Hum Reprod 2001; 7: 987-94.
  • 5Nuti F, Krausz C. Gene polymorphisms/mutations relevant to abnormal spermatogenesis. Reprod Biomed Online 2008; 6: 504-13.
  • 6O' Flynn O' Brien KL, Varghese AC, Agarwal A. The genetic causes of male factor infertility: a review. Fertil Steril2010; 93: 1-12.
  • 7Simoni M, Bakker E, Eurlings MC, Matthijs G, Moro E etal. Laboratory guidelines for molecular diagnosis of Y-chromosomal microdeletions. InJAndrol1999; 22: 292-9.
  • 8Simoni M, Bakker E, Krausz C. EAA/EMQN best practice guidelines for molecular diagnosis of Y-chromosomal microdeletions. State of the art 2004. In J Androl 2004; 27:240-9.
  • 9Foresta C, Moro E, Ferlin A. Y chromosome microdeletions and alterations of spermatogenesis. Endocr Rev 2001; 22 :226-39.
  • 10Stahl P J, Masson P, Mielnik A, Marean MB, Schlegel PN etal. A decade of experience emphasizes that testing for Y microdeletions is essential in American men with azoospermia and severe oligozoospermia. Fertil Steril2010; 94: 1753-6.

共引文献33

同被引文献19

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部